EPS for Ply Gem Holdings (PGEM) Expected At $0.50; Akebia Therapeutics (AKBA) Shorts Raised By 17.04%

October 13, 2017 - By Louis Casey

Akebia Therapeutics Incorporated (NASDAQ:AKBA) had an increase of 17.04% in short interest. AKBA’s SI was 2.19M shares in October as released by FINRA. Its up 17.04% from 1.87 million shares previously. With 435,800 avg volume, 5 days are for Akebia Therapeutics Incorporated (NASDAQ:AKBA)’s short sellers to cover AKBA’s short positions. The SI to Akebia Therapeutics Incorporated’s float is 15.06%. About 148,200 shares traded. Akebia Therapeutics Inc (NASDAQ:AKBA) has risen 76.80% since October 13, 2016 and is uptrending. It has outperformed by 60.10% the S&P500.

Analysts expect Ply Gem Holdings Inc (NYSE:PGEM) to report $0.50 EPS on November, 6.They anticipate $0.25 EPS change or 33.33% from last quarter’s $0.75 EPS. PGEM’s profit would be $34.12 million giving it 8.43 P/E if the $0.50 EPS is correct. After having $0.44 EPS previously, Ply Gem Holdings Inc’s analysts see 13.64% EPS growth. About 42,096 shares traded. Ply Gem Holdings Inc (NYSE:PGEM) has risen 22.22% since October 13, 2016 and is uptrending. It has outperformed by 5.52% the S&P500.

Akebia Therapeutics, Inc. is a biopharmaceutical company. The company has market cap of $877.49 million. The Firm focuses on the development and commercialization of therapeutics based on hypoxia-inducible factor biology. It currently has negative earnings. The Company’s lead product candidate, vadadustat, is indicated for the treatment of anemia in chronic kidney disease (CKD).

Investors sentiment increased to 2.25 in 2017 Q2. Its up 1.17, from 1.08 in 2017Q1. It increased, as 10 investors sold Akebia Therapeutics Inc shares while 22 reduced holdings. 38 funds opened positions while 34 raised stakes. 26.05 million shares or 30.12% more from 20.02 million shares in 2017Q1 were reported. 55,075 were reported by Piermont Cap. Voloridge Mngmt Ltd Company holds 0.01% of its portfolio in Akebia Therapeutics Inc (NASDAQ:AKBA) for 34,090 shares. Fmr Lc owns 1.04M shares for 0% of their portfolio. Invesco owns 120,578 shares. Highbridge Cap Mngmt Limited Company reported 0.01% of its portfolio in Akebia Therapeutics Inc (NASDAQ:AKBA). Panagora Asset Mngmt accumulated 30,126 shares. First Manhattan invested in 0.15% or 1.19 million shares. Proshare Advsr Limited Liability Company holds 0% or 23,208 shares in its portfolio. Jacobs Levy Equity Management Incorporated invested in 0.01% or 19,480 shares. Blackrock holds 0% of its portfolio in Akebia Therapeutics Inc (NASDAQ:AKBA) for 2.74 million shares. Renaissance Techs Limited Liability Company stated it has 1.03M shares. Foresite Cap Ii has invested 0.33% in Akebia Therapeutics Inc (NASDAQ:AKBA). Jane Street Grp Limited Liability Company invested in 0% or 26,186 shares. Ra Cap Management Ltd Limited Liability Company invested 1.38% in Akebia Therapeutics Inc (NASDAQ:AKBA). Eagle Asset reported 3.53M shares.

Among 9 analysts covering Akebia Therapeutics Inc (NASDAQ:AKBA), 7 have Buy rating, 0 Sell and 2 Hold. Therefore 78% are positive. Akebia Therapeutics Inc had 21 analyst reports since August 13, 2015 according to SRatingsIntel. The company was maintained on Friday, June 30 by Aegis Capital. H.C. Wainwright maintained the shares of AKBA in report on Tuesday, December 27 with “Buy” rating. The firm earned “Buy” rating on Tuesday, December 15 by H.C. Wainwright. JMP Securities maintained the stock with “Market Outperform” rating in Wednesday, March 9 report. Credit Suisse initiated the shares of AKBA in report on Thursday, January 21 with “Neutral” rating. H.C. Wainwright initiated it with “Buy” rating and $24 target in Monday, December 7 report. Morgan Stanley initiated it with “Equal Weight” rating and $10 target in Thursday, August 13 report. The firm has “Buy” rating by Aegis Capital given on Monday, June 5. H.C. Wainwright maintained the shares of AKBA in report on Wednesday, August 9 with “Buy” rating. The company was maintained on Monday, July 10 by H.C. Wainwright.

Ply Gem Holdings, Inc. is a manufacturer of exterior building products in North America. The company has market cap of $1.15 billion. The Firm operates through two divisions: Siding, Fencing, and Stone, and Windows and Doors. It has a 13.19 P/E ratio. In the Siding, Fencing, and Stone segment, its principal products include vinyl siding and skirting, vinyl and aluminum soffit, aluminum trim coil, cellular PVC trim and moldings, J-channels, wide crown molding, window and door trim, F-channels, H-molds, fascia, undersill trims, outside/inside corner posts, rain removal systems, injection molded designer accents, such as shakes, shingles, scallops, shutters, vents and mounts, vinyl fence, vinyl railing and stone veneer in the United States and Canada.

Investors sentiment decreased to 1.1 in 2017 Q2. Its down 0.19, from 1.29 in 2017Q1. It turned negative, as 15 investors sold Ply Gem Holdings Inc shares while 35 reduced holdings. 13 funds opened positions while 42 raised stakes. 20.31 million shares or 1.52% more from 20.00 million shares in 2017Q1 were reported. Credit Suisse Ag stated it has 13,842 shares. Bbt Capital Management Ltd Limited Liability Company has 0.13% invested in Ply Gem Holdings Inc (NYSE:PGEM) for 55,379 shares. Cna owns 22,467 shares or 0.09% of their US portfolio. Meeder Asset Management Inc reported 0% of its portfolio in Ply Gem Holdings Inc (NYSE:PGEM). Northern Tru Corp has invested 0% of its portfolio in Ply Gem Holdings Inc (NYSE:PGEM). Malaga Cove Cap Limited accumulated 1.22% or 113,475 shares. National Bank Of America Corporation De invested in 0% or 307,493 shares. Goldman Sachs Inc stated it has 0% in Ply Gem Holdings Inc (NYSE:PGEM). Kennedy Capital Management Inc, a Missouri-based fund reported 287,598 shares. Principal Grp Inc owns 200,687 shares or 0% of their US portfolio. D E Shaw & Com accumulated 107,044 shares. 59,424 are held by Convergence Prns Ltd. Gsa Capital Partners Llp has 10,610 shares. Pzena Invest Mgmt Ltd Liability invested in 859,716 shares or 0.08% of the stock. Numeric reported 292,406 shares.

Among 7 analysts covering Ply Gem Holdings (NYSE:PGEM), 4 have Buy rating, 0 Sell and 3 Hold. Therefore 57% are positive. Ply Gem Holdings had 15 analyst reports since August 11, 2015 according to SRatingsIntel. The firm has “Buy” rating by Deutsche Bank given on Tuesday, August 11. RBC Capital Markets maintained the stock with “Buy” rating in Monday, June 19 report. The rating was maintained by JP Morgan on Tuesday, August 9 with “Neutral”. On Wednesday, April 12 the stock rating was maintained by RBC Capital Markets with “Buy”. The stock of Ply Gem Holdings Inc (NYSE:PGEM) earned “Sector Weight” rating by KeyBanc Capital Markets on Tuesday, October 18. RBC Capital Markets maintained Ply Gem Holdings Inc (NYSE:PGEM) on Monday, September 11 with “Buy” rating. RBC Capital Markets initiated the stock with “Outperform” rating in Tuesday, September 20 report. The stock of Ply Gem Holdings Inc (NYSE:PGEM) earned “Buy” rating by RBC Capital Markets on Tuesday, August 8. The rating was upgraded by Zelman on Tuesday, March 14 to “Buy”. RBC Capital Markets maintained Ply Gem Holdings Inc (NYSE:PGEM) rating on Monday, July 24. RBC Capital Markets has “Buy” rating and $2200 target.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Twitter Auto Publish Powered By : XYZScripts.com